The FDA is failing children with a rare, neglected disease sometimes called childhood dementia

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Related Keywords

,Drug Administration ,Sanfilippo Syndrome ,Food And Drug Administration ,Heparan Sulfate ,